Seven & i Q2 FY2027: Overseas CVS drives profit surge on yen weakness.
Revenue
¥5.5T
-2.8%
Full-year forecast
¥10.4T
Operating Profit
¥232.3B
+11.5%
Full-year forecast
¥425.0B
Net Income
¥124.4B
+2.2%
Full-year forecast
¥278.0B
Operating Margin
4.3%
Seven & i Holdings reported a 11.5% rise in operating profit for Q2 FY2027, driven by robust performance from its North American 7-Eleven unit. This growth offset a 2.8% drop in consolidated revenue caused by the exclusion of key entities.
Financial Highlights
For the second quarter of FY2027, Seven & i posted consolidated operating revenue of 5.46 trillion yen, a 2.8% decline from the same period last year. This drop is primarily attributable to the exclusion of York Holdings and Seven Bank from consolidation; comparisons should therefore focus on operational metrics rather than top-line size.
Profitability remained strong, with operating profit rising 11.5% to 232.28 billion yen and current income increasing 19.0% to 221.92 billion yen. Net income attributable to parent shareholders grew 2.2% to 124.44 billion yen, demonstrating improved margins.
Exchange rates played a pivotal role. The weakening yen boosted the value of North American operations, adding approximately 311 billion yen to operating revenue and 94 billion yen to profit. On a comparable basis focusing solely on CVS operations, operating revenue surged 16.3% and operating profit jumped 36.6%, indicating genuine operational improvement.
Management reaffirmed its commitment to shareholder returns, raising the full-year dividend forecast by 12 yen to 60 yen per share.
Segment Performance
Following a segment restructuring in April 2026, performance is categorized into domestic CVS, overseas CVS, and other businesses.
The overseas CVS segment emerged as the primary profit engine, reporting operating revenue of 4.97 trillion yen (up 17.7%) and operating profit of 150.42 billion yen, a staggering 87.7% increase. This growth was fueled by new product rollouts, store renovations, and strong fuel margins at 7-Eleven, Inc. in the United States. Profit before goodwill amortization grew 155.5%, marking this unit as a critical pillar of group profitability.
Domestic CVS revenue increased slightly to 46.73 billion yen (+1.0%), but operating profit fell 9.8% to 10.99 billion yen. Rising input costs and investments in next-generation store systems and the "Live-Meal" initiative pressured margins, despite stable unit sales.
| Segment | Operating Revenue (Million Yen) | YoY Change | Operating Profit (Million Yen) | YoY Change |
|---|---|---|---|---|
| Domestic CVS | 467,322 | +1.0% | 109,899 | -9.8% |
| Overseas CVS | 4,966,613 | +17.7% | 150,422 | +87.7% |
| Other Business | 32,383 | +3.4% | 2,749 | +6.6% |
Other businesses, now containing residual financial and retail units, maintained profitability despite a smaller consolidated scope.
The results confirm the group's structural shift toward reliance on overseas earnings.
| Segment | Revenue | Share | Op. Profit | Op. Margin |
|---|---|---|---|---|
| 国内コンビニエンスストア事業 | ¥467.3B | 9% | ¥109.9B | 23.5% |
| 海外コンビニエンスストア事業 | ¥5.0T | 91% | ¥150.4B | 3.0% |
| その他の事業 | ¥32.4B | 1% | ¥2.7B | 8.5% |
Financial Position & Capital Policy
Total assets grew 325.5 billion yen to 9.47 trillion yen, driven by exchange rate effects and increased usage rights for overseas stores. While the equity-to-assets ratio dipped 0.5 percentage points to 39.1% due to asset expansion, the underlying financial health remains robust with net assets rising to 3.74 trillion yen.
Operating cash flow generated a surplus of 337.08 billion yen, supporting ongoing facility investments.
Shareholder returns are accelerating. The interim dividend is set at 30 yen per share, confirming the full-year forecast of 60 yen. Additionally, a 40 billion yen stock buyback program in August 2026 underscores a dual approach to lowering capital costs through dividends and buybacks.
| Metric | Q2 FY2027 End | Prior Year-End | Change |
|---|---|---|---|
| Total Assets | 9,468,412 | 9,142,957 | +325,455 |
| Net Assets | 3,735,086 | 3,648,195 | +86,890 |
| Equity Ratio | 39.1% | 39.6% | -0.5p |
Liabilities increased to 5.73 trillion yen, though liquidity risks remain low with active debt repayment plans in place.
Risks & Challenges
Management identified several key risks:
1. Exchange rate and interest rate volatility are the most significant external factors. While a weak yen currently boosts earnings, a rapid shift to a strong yen could result in valuation losses on unhedged assets.
2. Shifting consumer behavior in the U.S.. High inflation has led to reduced spending among lower-income demographics on groceries and essentials. The company is responding with value-focused product development to mitigate sales volume risks.
3. Rising costs for domestic operations. Labor and material cost increases continue to pressure margins. Investments in digital tools and food preparation are essential for long-term competitiveness but weigh on short-term profitability.
4. Operational risks including natural disasters, supply chain disruptions, and geopolitical tensions persist despite enhanced management systems.
Full-Year Outlook
Seven & i maintained its full-year FY2027 forecasts at levels similar to the previous fiscal year.
| Item | Prior Year Actual (Million Yen) | Full-Year Forecast (Million Yen) | YoY Change |
|---|---|---|---|
| Operating Revenue | 10,400,000 | 10,430,000 | +0.3% |
| Operating Profit | 422,500 | 425,000 | +0.6% |
| Current Income | 385,000 | 390,000 | +1.3% |
| Net Income | 300,000 | 278,000 | -7.3% |
The decline in net income relative to the prior year is largely due to the reduced contribution from financial and supermarket segments rather than weakness in the core CVS business.
Given the 11.5% profit growth in Q2, an upward revision for the full year remains possible if domestic costs remain controlled and exchange rates stay favorable.
Analyst take
The core narrative of this interim report is the shift away from yen-weakness dependency toward a profitable overseas business model. Investors should look past the consolidated revenue decline and focus on the reality that North American 7-Eleven now generates over half of the group's operating profit.
For Seven & i, the U.S. market has evolved from an 'overseas segment' into the primary pillar supporting corporate valuation. The stock price will increasingly depend on managing U.S. inflation and consumer spending risks, rather than just currency fluctuations.
Domestic CVS margins face prolonged pressure from structural costs, meaning short-term profitability recovery may be slow. However, clear capital efficiency via a 60 yen annual dividend and significant buybacks makes the valuation attractive amidst stable stock prices.
Potential concern is the slow pace of domestic structural reform. While dependence on overseas profits offers stability, it requires resilience against intense price competition with rivals like Walmart in the U.S. Monitoring hedging strategies against potential yen appreciation in the second half is critical.